This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ...
Date First Received: September 8, 2005
Last Updated: July 13, 2007
Verified by: Solvay Pharmaceuticals, July 2007
Clinical Trial Phase: N/A | Start Date: October 2004
Overall Status: Completed
Estimated Enrollment: 440
Brief Summary
Official Title: “A Multi-Center, Double-Blind, Randomized Study Comparing the Efficacy of Combination Therapy of Eprosartan Respectively Ramipril With Low-Dose Hydrochlorothiazide and Moxonidine on Blood Pressure Levels in Patients With Hypertension and Associated Diabetes Mellitus Type 2”
Condition Keyword(s):
Intervention(s):
This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: eprosartan/HCTZ
Outcome Measures for this Clinical Trial
Primary Measures
- Blood pressure reduction
Secondary Measures
- Comparison of responder rates
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- essential hypertension,
- diabetes type 2
Exclusion Criteria:
- severe cardiovascular disease,
- grade 3 hypertension,
- secondary hypertension,
- abnormal liver enzymes
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 40 Years
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Solvay Pharmaceuticals
Overall Clinical Trial Officials and Contacts
Global Clinical Director Solvay Study Director Solvay Pharmaceuticals
Additional Information
Information obtained from ClinicalTrials.gov on August 20, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00160160
Study ID Number: S171.3.012
ClinicalTrials.gov Identifier: NCT00160160
Health Authority: Germany: Federal Institute for Drugs and Medical Devices
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
